Two Sigma Securities’s Achieve Life Sciences ACHV Stock Holding History

Two Sigma Securities’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-72	Closed	-$29K	–	1704
2017 Q3	$29K	Buy	+72	New	+$51.7K	﹤0.01%	790
2017 Q1	–	Sell	-8	Closed	-$9K	–	873
2016 Q4	$9K	Buy	+8	New	+$7.9K	﹤0.01%	676
2016 Q1	–	Sell	-5	Closed	-$13K	–	295
2015 Q4	$13K	Buy	+5	New	+$21.1K	0.02%	217

Other funds holding ACHV

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Two Sigma Securities's ACHV Position: Q4 2017 in Review

Two Sigma Securities sold out of Achieve Life Sciences (ACHV) in Q4 2017, closing a stake of 72 shares — an estimated $29K sold.

Two Sigma Securities first reported a position in ACHV in Q4 2015 and held it in 3 quarters. The position peaked at $29K in Q3 2017. 12 funds tracked by Wall St. Rank hold ACHV as of Q4 2017.

Two Sigma Securities reported no remaining Achieve Life Sciences position as of Q4 2017 after selling out during the quarter.
Two Sigma Securities sold 72 Achieve Life Sciences shares in Q4 2017, an estimated $29K.
Two Sigma Securities first reported a position in Achieve Life Sciences in Q4 2015 and held it in 3 quarters.
Two Sigma Securities's Achieve Life Sciences position peaked at $29K in Q3 2017.
12 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2017.

Based on Two Sigma Securities's 13F filing for Q4 2017, filed 14 Feb 2018.